Weighty question: does dosing method affect survival in brain infection?
NCT ID NCT05127395
Summary
This study looked back at medical records to see if the way doctors calculate acyclovir doses for obese patients with HSV encephalitis (a serious brain infection) affects survival. Researchers examined 50 patients across six hospitals to compare outcomes when doses were based on ideal body weight versus adjusted body weight. The goal was to determine which dosing approach leads to better results for these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSV ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Charlton Medical Center
Dallas, Texas, 75237, United States
Conditions
Explore the condition pages connected to this study.